Ajay Sheshadri, MD, MSCI

Peer-Reviewed Articles

1. Sheshadri A, Marathe S, Sadowski L, Shree B. Machine learning-driven optimization of alkali-activated sustainable pavement concrete incorporating agro-industrial wastes. Sci Rep, 2026. e-Pub 2026. PMID: 42259843.
2. Yadav H, White B, Soto F, Zhang Z, Pennington K, Adarsh S, Smilnak G, Sturek J, Cheng GS, Sheshadri A. FEV1Q: A Race-Neutral Approach to Risk Assessment in Allogeneic Hematopoietic Cell Transplantation. Ann Am Thorac Soc, 2026. e-Pub 2026. PMID: 42127995.
3. Chean D, Dupont T, Nates JL, Manjappachar NK, Medic M, Aygencel G, Orvain C, Kouatchet A, Sheshadri A, Haque TK, Russell L, Pabst T, Turkoglu M, Ostermann M, Soares M, Cetintepe T, Buckstein R, Issa N, Mokart D, Caruso P, Cornejo-Juarez P, Schnell D, Lahmer T, Fodil S, Lengline E, Luque-Paz D, Lemiale V, Poole D, Darmon M, Azoulay E. Temporal trends and prognostic factors in critically ill adult patients with acute leukemia: an individual participant data meta-analysis. Intensive Care Med, 2026. e-Pub 2026. PMID: 42081104.
4. Muneer A, Showkatian E, Kitsel Y, Saad MB, Sujit SJ, Soto F, Shroff GS, Faiz SA, Ghanbar MI, Ismail SM, Vokes NI, Cascone T, Le X, Zhang J, Byers LA, Jaffray D, Chang JY, Liao Z, Naing A, Gibbons DL, Vaporciyan AA, Heymach JV, Suresh KS, Altan M, Sheshadri A, Wu J. CT-Based Deep Foundation Model for Predicting Immune Checkpoint Inhibitor-Induced Pneumonitis Risk in Lung Cancer. medRxiv, 2026. e-Pub 2026. PMID: 42078359.
5. Shinde R, Ankur K, Phillips CE, Gupta A, Pfreundschuh S, Roy S, Kirkland S, Gaur V, Kolluru V, Lin A, Trital P, Sheshadri A, Nair U, Maskey M, Ramachandran R. WxC-Bench: A Novel Dataset for Weather and Climate Downstream Tasks. Sci Data 13(1), 2026. e-Pub 2026. PMID: 41786786.
6. Bashour SI, Khan A, Balachandran DD, Ost D, Eapen G, Casal R, Adachi R, Bassett R, Pasyar S, Bashoura L, Vaquero L, Ordonez E, Zaveri J, Faiz SA, Sheshadri A, Depew Z, Grosu HB. Using actigraphy to evaluate physical activity in patients with pleural effusion: a pilot study. J Thorac Dis 18(2):141, 2026. e-Pub 2026. PMID: 41816437.
7. Azhar M, Soto F, Su A, Gonzalez NAV, Medina KB, Madrigal AL, Duran CC, Reyna CIR, Chan C, Shroff GS, Bassett RL, Pasyar S, Zhang D, Shannon VR, Altan M, Mitchell MP, Meric-Bernstam F, Mouabbi J, Murthy RK, Faiz SA, Bashoura L, Lim B, Sheshadri A. Incidence and risk factors for pneumonitis due to trastuzumab Deruxtecan in metastatic breast cancer: a retrospective cohort study. Breast Cancer Res 27(1):197, 2025. e-Pub 2025. PMID: 41194091.
8. Sharifi H, Moss CT, Musa Z, Bell A, O'Donnell C, Borges CH, Matthaiou EI, Johnston L, Galban CJ, Sheshadri A, Yanik G, Cheng GS, Hsu JL. Pirfenidone for the treatment of bronchiolitis obliterans syndrome related to chronic graft-versus-host disease. Blood Adv 9(19):5024-5037, 2025. e-Pub 2025. PMID: 40554417.
9. Brandow AM, Atkinson SN, Manjarres Z, Ehlers VL, Pratt ML, Mehta I, Mudunuri S, Kappagantu A, Shiers SI, Mazhar K, Simms MA, Alhendi S, Sheshadri A, Cervantes AM, Reese JC, Tavares-Ferreira D, Sankaranarayanan I, Schaub MK, Waltz TB, Hayward M, Rodriguez Garcia DM, Dussor G, Salzman NH, Palmer KL, Stucky CL, Price TJ, Sadler KE. Gut microbiota and metabolites drive chronic sickle cell disease pain in mice. Cell Host Microbe 33(10):1703-1714.e8, 2025. e-Pub 2025. PMID: 40961935.
10. Sun T, Zanocco C, Flora J, Sheshadri A, Rajagopal R. Unified 0.25-degree gridded infrastructure-critical extreme weather for the United States from 1979 to 2100. Sci Data 12(1):1544, 2025. e-Pub 2025. PMID: 40940354.
11. Soto, F, Ebinama, U, Brasher, WP, Harding, WC, Goizueta, AA, Walder, JR, Ewing, A, Shannon, VR, Faiz, S, Altan, M, Shroff, G, Feng, L, Neelapu, SS, Ahmed, S, Nastoupil, L, Sheshadri, A. Incidence and Risk Factors for Pneumonitis Associated With Checkpoint Inhibitors in Relapsed or Refractory Lymphoma. Clinical Lymphoma, Myeloma and Leukemia 25(9):e649-e655, 2025. e-Pub 2025. PMID: 40514309.
12. Brehm, V, Wang, Z, Rocha, L, Jones, B, Jenq, RR, Chang, C, Cheng, GS, Hsu, JL, Sharifi, H, Yanik, G, Luna, L, Waqar, A, Zaveri, JS, Dickey, BF, Bashoura, L, Shpall, E, Zinter, MS, O'Dwyer, D, Champlin, RE, Chen, GL, Alousi, AM, Paczesny, S, Peterson, CB, Sheshadri, A. Inflammatory Markers and Microbiome Dysbiosis in Hematopoietic Cell Transplant Recipients with Lung Graft-versus-Host Disease. Transplantation and Cellular Therapy 31(9):668.e1-668.e12, 2025. e-Pub 2025. PMID: 40543709.
13. Rajaram, R, Sheshadri, A, Baugh, A, Bonnell, LN, Li, L, Vaporciyan, AA, Block, M, David, E, Habib, RH, Ost, D. Race-Specific versus Race-Neutral Pulmonary Function Predicted Values in Patients with Operable Lung Cancer. Annals of the American Thoracic Society 22(8):1244-1253, 2025. e-Pub 2025. PMID: 40153590.
14. Cheng GS, Sheshadri A, Turner J, Williams KM, Hsu JL, Agoritsas T, Ali MH, Bondeelle L, Bouguet G, Chanez P, Cooke KR, Galban CJ, Goldfarb S, Hallstrand TS, Johnson S, Lam DCL, Michonneau D, O'Dwyer DN, Paczesny S, Sharifi H, Todd JL, Wolff D, Yadav H, Yanik GA, Bergeron A. Addressing Knowledge Gaps in the Early Detection of Bronchiolitis Obliterans Syndrome after Hematopoietic Cell Transplantation: An Official American Thoracic Society Research Statement. Am J Respir Crit Care Med 211(8):1369-1390, 2025. e-Pub 2025. PMID: 40569102.
15. Saad MB, Al-Tashi Q, Hong L, Verma V, Li W, Boiarsky D, Li S, Petranovic M, Wu CC, Carter BW, Shroff GS, Cascone T, Le X, Elamin YY, Altan M, Heeke S, Sheshadri A, Chang JY, Lee PP, Liao Z, Gibbons DL, Vaporciyan AA, Lee JJ, Wistuba II, Haymaker C, Mirjalili S, Jaffray D, Gainor JF, Lou Y, Di Federico A, Pecci F, Awad M, Ricciuti B, Heymach JV, Vokes NI, Zhang J, Wu J. Machine-learning driven strategies for adapting immunotherapy in metastatic NSCLC. Nat Commun 16(1):6828, 2025. e-Pub 2025. PMID: 40707438.
16. Marathe S, Sheshadri A, Nikolaiev V. Life cycle assessment of sustainable air-cured alkali-activated concrete for permeable pavements using agro-industrial wastes. Sci Rep 15(1):22012, 2025. e-Pub 2025. PMID: 40593963.
17. Walder, JR, Soto-Lanza, F, Feng, L, Ahmed, S, Neelapu, SS, Ayers, AA, Grosu, HB, Faiz, S, Nastoupil, L, Sheshadri, A. Role of Pulmonary Function Tests to Predict Complications After Chimeric Antigen Receptor T-Cell Therapy. Clinical Lymphoma, Myeloma and Leukemia 25(7):520-526, 2025. e-Pub 2025. PMID: 40000355.
18. Alkhunaizi, M, Soto-Lanza, F, Leung, CH, Bhan, N, Bashoura, L, Dickey, BF, Sharifi, H, Cheng, GS, Yanik, G, Rondon, G, Saliba, RM, Chen, GL, Al-Atrash, G, Hosing, C, Kebriaei, P, Popat, UR, Shpall, E, Champlin, RE, Li, L, Alousi, AM, Sheshadri, A. Restrictive Ventilatory Defects Following Hematopoietic Stem Cell Transplant Are Associated With Increased Mortality. Transplantation and Cellular Therapy 31(4):255.e1-255.e10, 2025. e-Pub 2025. PMID: 39921208.
19. Gower WA, Tamae-Kakazu M, Shanthikumar S, Srinivasan S, Reardon EE, Barochia AV, Charbek E, Calvo C, Cheng PC, Das S, Davies SM, Gross J, Sheshadri A, Towe CT, Goldfarb SB, Iyer NP. Pulmonary function testing in pediatric allogeneic stem cell transplant recipients to monitor for Bronchiolitis obliterans syndrome: a systematic review. BMC Pediatr 25(1):250, 2025. e-Pub 2025. PMID: 40155876.
20. Butler CR, Nalatwad A, Cheung KL, Hannan MF, Hladek MD, Johnston EA, Kimberly L, Liu CK, Nair D, Ozdemir S, Saeed F, Scherer JS, Segev DL, Sheshadri A, Tennankore KK, Washington TR, Wolfgram D, Ghildayal N, Hall R, McAdams-DeMarco M. Establishing Research Priorities in Geriatric Nephrology: A Delphi Study of Clinicians and Researchers. Am J Kidney Dis 85(3):293-302, 2025. e-Pub 2025. PMID: 39603330.
21. Simbaqueba Clavijo C, Odaro O, Gandhi A, Koom-Dadzie K, Musaelyan A, Dickson K, Chua R, Bhise V, Amoateng M, Tomy S, Leal Alviarez D, Phyu EM, Bogdanich I, Andersen C, Sheshadri A, Palaskas NL, Halm J, Manzano J. Immunotherapy-Related Adverse Events and Clinical Outcomes in Adult Solid-Tumor Patients Admitted to an Onco-Hospitalist Medicine Service. Cancers (Basel) 17(3), 2025. e-Pub 2025. PMID: 39941771.
22. Reyna, CR, Luna, ET, Sheshadri, A, Faiz, S, Bashoura, L, Box, N. Nocardia empyema in an immunocompromised host. Respiratory Medicine Case Reports 55, 2025. e-Pub 2025. PMID: 40271537.
23. Joshi S, Pathak A, Regati DR, Menon R, Ajith DS, Sheshadri A, Viswanathan N, Ray P, Koul V, Panda P, Bhambore SA, Verma S, Sinha A, Shafi KM, Pavalam M, Sowdhamini R. GRAYU: graph-based database integrating Ayurvedic formulations, medicinal plants, phytochemicals and diseases. Front Pharmacol 16:1727224, 2025. e-Pub 2025. PMID: 41657773.
24. Mir M, Soto F, Gomez PAA, Arroyo RDR, Suresh A, Su A, Gan Q, Stewart J, Adachi R, Balachandran DD, Bashoura L, Casal RF, Dickey BF, Eapen GA, Evans SE, Grosu H, Jimenez CA, Lin J, Ost DE, Sabath BF, Shannon VR, Naing A, Gao J, Wu J, Suresh K, Faiz SA, Altan M, Sheshadri A. Bronchoalveolar lavage cell percentages as diagnostic markers of immune checkpoint inhibitor pneumonitis. Front Med (Lausanne) 12:1582714, 2025. e-Pub 2025. PMID: 40529125.
25. Altan M, Li R, Li Z, Chen R, Sheshadri A, Tran HT, Little L, Baguley J, Sinson J, Vokes N, Gandhi S, Antonoff MB, Swisher SG, Lizee G, Reuben A, Heymach JV, Zhang J. High peripheral T cell diversity is associated with lower risk of toxicity and superior response to dual immune checkpoint inhibitor therapy in patients with metastatic NSCLC. J Immunother Cancer 12(12), 2024. e-Pub 2024. PMID: 39721752.
26. Shojaee S, Pannu J, Yarmus L, Fantin A, MacRosty C, Bassett R Jr, Debiane L, DePew ZS, Faiz SA, Jimenez CA, Avasarala SK, Vakil E, DeMaio A, Bashoura L, Keshava K, Ferguson T, Adachi R, Eapen GA, Ost DE, Bashour S, Khan A, Shannon V, Sheshadri A, Casal RF, Evans SE, Pew K, Castaldo N, Balachandran DD, Patruno V, Lentz R, Pai C, Maldonado F, Roller L, Ma J, Zaveri J, Los J, Vaquero L, Ordonez E, Yermakhanova G, Akulian J, Burks C, Almario RR, Sauve M, Pettee J, Noor LZ, Arain MH, Grosu HB. Gravity- vs Wall Suction-Driven Large-Volume Thoracentesis: A Randomized Controlled Study. Chest 166(6):1573-1582, 2024. e-Pub 2024. PMID: 39029784.
27. Desai A, Subbiah V, Roy-Chowdhuri S, Sheshadri A, Deshmukh S, Peters S. Association of Antibody-Drug Conjugate (ADC) Target Expression and Interstitial Lung Disease (ILD) in Non-Small-Cell Lung Cancer (NSCLC): Association or Causation or Neither?. Cancers (Basel) 16(22), 2024. e-Pub 2024. PMID: 39594708.
28. Soto-Lanza, F, Glick, L, Chan, C, Zhong, L, Wilson, NR, Faiz, S, Gandhi, S, Naing, A, Heymach, JV, Shannon, VR, Franco Vega, M, Liao, Z, Lin, SH, Palaskas, NL, Wu, J, Shroff, G, Altan, M, Sheshadri, A. Long-Term Clinical, Radiological, and Mortality Outcomes Following Pneumonitis in Nonsmall Cell Lung Cancer Patients Receiving Immune Checkpoint Inhibitors. Clinical Lung Cancer 25(7):624-633.e2, 2024. e-Pub 2024. PMID: 39183094.
29. Walder, JR, Faiz, S, Tummala, S, Weathers, S, Palaskas, NL, Buni, M, Sheshadri, A, Bashoura, L. Diaphragmatic Myopathy Associated with Dual Immune Checkpoint Inhibitors in a Patient with Renal Cell Carcinoma. Journal of Immunotherapy and Precision Oncology 7(4):304-307, 2024. e-Pub 2024. PMID: 39553443.
30. Sharifi H, Bertini CD, Alkhunaizi M, Hernandez M, Musa Z, Borges C, Turk I, Bashoura L, Dickey BF, Cheng GS, Yanik G, Galban CJ, Guo HH, Godoy MCB, Reinhardt JM, Hoffman EA, Castro M, Rondon G, Alousi AM, Champlin RE, Shpall EJ, Lu Y, Peterson S, Datta K, Nicolls MR, Hsu J, Sheshadri A. CT strain metrics allow for earlier diagnosis of bronchiolitis obliterans syndrome after hematopoietic cell transplant. Blood Adv 8(19):5156-5165, 2024. e-Pub 2024. PMID: 39163616.
31. Shanthikumar, S, Gower, WA, Srinivasan, S, Rayment, J, Robinson, PD, Bracken, J, Stone, A, Das, S, Barochia, A, Charbek, E, Tamae-Kakazu, M, Reardon, EE, Abts, M, Blinman, T, Calvo, C, Cheng, PC, Cole, TS, Cooke, KR, Davies, SM, De, A, Gross, J, Mechinaud, F, Sheshadri, A, Siddaiah, R, Teusink-Cross, A, Towe, CT, Walkup, LL, Yanik, G, Bergeron, A, Casey, A, Deterding, RR, Liptzin, DR, Schultz, KR, Iyer, NP, Goldfarb, S. Detection of Bronchiolitis Obliterans Syndrome after Pediatric Hematopoietic Stem Cell Transplantation An Official American Thoracic Society Clinical Practice Guideline. American Journal of Respiratory and Critical Care Medicine 210(3):262-280, 2024. e-Pub 2024. PMID: 38889365.
32. Aminu M, Hong L, Vokes N, Schmidt ST, Saad M, Zhu B, Le X, Tina C, Sheshadri A, Wang B, Jaffray D, Futreal A, Lee JJ, Byers LA, Gibbons D, Heymach J, Chen K, Cheng C, Zhang J, Wu J. Joint multi-omics discriminant analysis with consistent representation learning using PANDA. Res Sq, 2024. e-Pub 2024. PMID: 38798352.
33. Sujit SJ, Aminu M, Karpinets TV, Chen P, Saad MB, Salehjahromi M, Boom JD, Qayati M, George JM, Allen H, Antonoff MB, Hong L, Hu X, Heeke S, Tran HT, Le X, Elamin YY, Altan M, Vokes NI, Sheshadri A, Lin J, Zhang J, Lu Y, Behrens C, Godoy MCB, Wu CC, Chang JY, Chung C, Jaffray DA, Wistuba II, Lee JJ, Vaporciyan AA, Gibbons DL, Heymach J, Zhang J, Cascone T, Wu J. Enhancing NSCLC recurrence prediction with PET/CT habitat imaging, ctDNA, and integrative radiogenomics-blood insights. Nat Commun 15(1):3152, 2024. e-Pub 2024. PMID: 38605064.
34. Samant M, Krings JG, Lew D, Goss CW, Koch T, McGregor MC, Boomer J, Hall CS, Schechtman KB, Sheshadri A, Peterson S, Erzurum S, DePew Z, Morrow LE, Hogarth DK, Tejedor R, Trevor J, Wechsler ME, Sam A, Shi X, Choi J, Castro M. Use of Quantitative CT Imaging to Identify Bronchial Thermoplasty Responders. Chest 165(4):775-784, 2024. e-Pub 2024. PMID: 38123124.
35. Corrigan KL, Xu T, Sasaki Y, Lin R, Chen AB, Welsh JW, Lin SH, Chang JY, Ning MS, Gandhi S, O'Reilly MS, Gay CM, Altan M, Lu C, Cascone T, Koutroumpakis E, Sheshadri A, Zhang X, Liao L, Zhu XR, Heymach JV, Nguyen QN, Liao Z. Survival outcomes and toxicity of adjuvant immunotherapy after definitive concurrent chemotherapy with proton beam radiation therapy for patients with inoperable locally advanced non-small cell lung carcinoma. Radiother Oncol 193:110121, 2024. e-Pub 2024. PMID: 38311031.
36. Salehjahromi M, Karpinets TV, Sujit SJ, Qayati M, Chen P, Aminu M, Saad MB, Bandyopadhyay R, Hong L, Sheshadri A, Lin J, Antonoff MB, Sepesi B, Ostrin EJ, Toumazis I, Huang P, Cheng C, Cascone T, Vokes NI, Behrens C, Siewerdsen JH, Hazle JD, Chang JY, Zhang J, Lu Y, Godoy MCB, Chung C, Jaffray D, Wistuba I, Lee JJ, Vaporciyan AA, Gibbons DL, Gladish G, Heymach JV, Wu CC, Zhang J, Wu J. Synthetic PET from CT improves diagnosis and prognosis for lung cancer: Proof of concept. Cell Rep Med 5(3):101463, 2024. e-Pub 2024. PMID: 38471502.
37. Shatila M, Eshaghi F, Thomas AR, Kuang AG, Shah JS, Zhao B, Naz S, Sun M, Fayle S, Jin J, Abudayyeh A, Sheshadri A, Palaskas NL, Franco-Vega MC, Gaeta MS, Thomas AS, Zhang HC, Wang Y. Practice Changes in Checkpoint Inhibitor-Induced Immune-Related Adverse Event Management at a Tertiary Care Center. Cancers (Basel) 16(2), 2024. e-Pub 2024. PMID: 38254858.
38. Sheshadri A, Rajaram R, Baugh A, Castro M, Correa AM, Soto F, Daniel CR, Li L, Evans SE, Dickey BF, Vaporciyan AA, Ost DE. Association of Preoperative Lung Function with Complications after Lobectomy Using Race-Neutral and Race-Specific Normative Equations. Ann Am Thorac Soc 21(1):38-46, 2024. e-Pub 2024. PMID: 37796618.
39. Dickey JS, Dickey BF, Alousi AM, Champlin RE, Sheshadri A. Early and rapid development of bronchiolitis obliterans syndrome after allogeneic hematopoietic cell transplantation. Respir Med Case Rep 49:102001, 2024. e-Pub 2024. PMID: 38745870.
40. Altan M, Li QZ, Wang Q, Vokes NI, Sheshadri A, Gao J, Zhu C, Tran HT, Gandhi S, Antonoff MB, Swisher S, Wang J, Byers LA, Abdel-Wahab N, Franco-Vega MC, Wang Y, Lee JJ, Zhang J, Heymach JV. Distinct Patterns of Auto Reactive Antibodies Associated with Organ-Specific Immune-Related Adverse Events. Front Immunol 14:1322818, 2023. e-Pub 2023. PMID: 38152395.
41. Balachandran DD, Bashoura L, Sheshadri A, Manzullo E, Faiz SA. The Impact of Immunotherapy on Sleep and Circadian Rhythms in Patients with Cancer. Front Oncol 13:1295267, 2023. e-Pub 2023. PMID: 38090501.
42. Alexander Franklin, Teny M John, Fareed Khawaja, Ying Jiang, Eduardo Yepez, Jitesh Ahuja, Saadia A Faiz, Lara Bashoura, Ajay Sheshadri, Vickie R Shannon, Diwakar D Balachandran, Kelly McConn. Utility of Bronchoalveolar Lavage for the Diagnosis and Management of COVID-19 in Cancer Patients. Journal of Infectious Disease 228(11):1549-1558, 2023. e-Pub 2023. PMID: 37983000.
43. Altan M, Soto F, Zhong LL, Akhmedzhanov FO, Wilson NR, Zarifa A, Albittar AA, Yang V, Lewis J, Rinsurongkawong W, Jack Lee J, Rinsurongkawong V, Zhang J, Gibbons DL, Vaporciyan AA, Jennings K, Khawaja F, Faiz SA, Shannon VR, Shroff G, Godoy MCB, Daver NG, Gandhi S, Mendoza TR, Naing A, Daniel-MacDougall C, Heymach JV, Sheshadri A. Incidence and Risk Factors for Pneumonitis Associated With Checkpoint Inhibitors in Advanced Non-Small Cell Lung Cancer: A Single Center Experience. Oncologist 28(11):e1065-e1074, 2023. e-Pub 2023. PMID: 37156009.
44. Wang S, Niroula S, Hoffman A, Khorrami M, Khorrami M, Yuan F, Gasser GN, Choi S, Liu B, Li J, Metersky ML, Vincent M, Crum CP, Boucher RC, Karmouty-Quintana H, Huang HJ, Sheshadri A, Dickey BF, Parekh KR, Engelhardt JF, McKeon FD, Xian W. Inflammatory Activity of Epithelial Stem Cell Variants from Cystic Fibrosis Lung Is Not Resolved by CFTR Modulators. Am J Respir Crit Care Med 208(9):930-943, 2023. e-Pub 2023. PMID: 37695863.
45. Ebinama U, Sheshadri A, Anand K, Swaminathan I. Pulmonary Immune-Related Adverse Events of PD1 versus PDL-1 Checkpoint Inhibitors: a retrospective review of pharmacovigilance. J Immunother Precis Oncol 6(4):177-184, 2023. e-Pub 2023. PMID: 38143955.
46. Altan M, Soto F, Xu T, Wilson N, Franco-Vega MC, Simbaqueba Clavijo CA, Shannon VR, Faiz SA, Gandhi S, Lin SH, Lopez P, Zhong L, Akhmedzhanov F, Godoy MCB, Shroff GS, Wu J, Khawaja F, Kim ST, Naing A, Heymach JV, Daniel-Macdougall C, Liao Z, Sheshadri A. Pneumonitis After Concurrent Chemoradiation and Immune Checkpoint Inhibition in Patients with Locally Advanced Non-small Cell Lung Cancer. Clin Oncol (R Coll Radiol) 35(10):630-639, 2023. e-Pub 2023. PMID: 37507279.
47. Noh S, Bertini C, Mira-Avendano I, Kaous M, Patel B, Faiz SA, Shannon VR, Balachandran DD, Bashoura L, Adachi R, Evans SE, Dickey B, Wu C, Shroff GS, Manzano JG, Granwehr B, Holloway S, Dickson K, Mohammed A, Muthu M, Song H, Team D, Chung C, Wu J, Lee L, Jiang Y, Khawaja F, Sheshadri A. Interstitial lung abnormalities after hospitalization for COVID-19 in patients with cancer: a prospective cohort study. Cancer Med 12(17):17753-17765, 2023. e-Pub 2023. PMID: 37592894.
48. Al-Tashi Q, Saad MB, Sheshadri A, Wu CC, Chang JY, Al-Lazikani B, Gibbons C, Vokes NI, Zhang J, Lee JJ, Heymach JV, Jaffray D, Mirjalili S, Wu J. SwarmDeepSurv: Swarm Intelligence Advances Deep Survival Network for Prognostic Radiomics Signatures in Four Solid Cancers. Patterns (N Y) 4(8):100777, 2023. e-Pub 2023. PMID: 37602223.
49. Greenhawt M, Dribin TE, Abrams EM, Shaker M, Chu DK, Golden DBK, Akin C, Anagnostou A, ALMuhizi F, Alqurashi W, Arkwright P, Baldwin JL, Banerji A, Bégin P, Ben-Shoshan M, Bernstein J, Bingemann TA, Bindslev-Jensen C, Blumenthal K, Byrne A, Cahill J, Cameron S, Campbell D, Campbell R, Cavender M, Chan ES, Chinthrajah S, Comberiati P, Eastman JJ, Ellis AK, Fleischer DM, Fox A, Frischmeyer-Guerrerio PA, Gagnon R, Garvey LH, Grayson MH, Isabwe GAC, Hartog N, Hendron D, Horner CC, Hourihane JO, Iglesia E, Kan M, Kaplan B, Katelaris CH, Kim H, Kelso JM, Khan DA, Lang D, Ledford D, Levin M, Lieberman JA, Loh R, Mack DP, Mazer B, Mody K, Mosnaim G, Munblit D, Mustafa SS, Nanda A, Nathan R, Oppenheimer J, Otani IM, Park M, Pawankar R, Perrett KP, Peter J, Phillips EJ, Picard M, Pitlick M, Ramsey A, Rasmussen TH, Rathkopf MM, Reddy H, Robertson K, Rodriguez Del Rio P, Sample S, Sheshadri A, Sheik J, Sindher SB, Spergel JM, Stone CA, Stukus D, Tang MLK, Tracy JM, Turner PJ, Vander Leek TK, Wallace DV, Wang J, Wasserman S, Weldon D, Wolfson AR, Worm M, Yacoub MR. Updated guidance regarding the risk of allergic reactions to COVID-19 vaccines and recommended evaluation and management: A GRADE assessment and international consensus approach. J Allergy Clin Immunol 152(2):309-325, 2023. e-Pub 2023. PMID: 37295474.
50. Ostrin EJ, Rider NL, Alousi AM, Irajizad E, Li L, Peng Q, Kim ST, Bashoura L, Arain MH, Noor LZ, Patel N, Mehta R, Popat UR, Hosing C, Jenq RR, Rondon G, Hanash SM, Paczesny S, Shpall EJ, Champlin RE, Dickey BF, Sheshadri A. A nasal inflammatory cytokine signature is associated with early graft-versus-host disease of the lung after allogeneic hematopoietic cell transplantation: proof of concept. Immunohorizons 7(6):421-430, 2023. e-Pub 2023. PMID: 37289498.
51. Williams LA, Whisenant MS, Mendoza TR, Peek AE, Malveaux D, Griffin DK, Ponce DA, Granwehr BP, Sheshadri A, Hutcheson KA, Ali SM, Peterson SK, Heymach JV, Cleeland CS, Subbiah IM. Measuring symptom burden in patients with cancer during a pandemic: The MD Anderson Symptom Inventory for COVID-19 (MDASI-COVID). J Patient Rep Outcomes 7(1):48, 2023. e-Pub 2023. PMID: 37237077.
52. Soto F, Torre-Sada LF, Mott FE, Kim ST, Nurieva R, Shannon VR, Faiz SA, Casal RF, Altan M, Lin J, Sheshadri A. Sarcoidosis and Airway Disease After Immune Checkpoint Inhibitor Therapy: Case Study and Review of the Literature. J Immunother Precis Oncol 6(2):111-116, 2023. e-Pub 2023. PMID: 37214206.
53. Wang S, Rao W, Hoffman A, Lin J, Li J, Lin T, Liew AA, Vincent M, Mertens TCJ, Karmouty-Quintana H, Crum CP, Metersky ML, Schwartz DA, Davies PJA, Stephan C, Jyothula SSK, Sheshadri A, Suarez EE, Huang HJ, Engelhardt JF, Dickey BF, Parekh KR, McKeon FD, Xian W. Cloning a Pro-fibrotic Stem Cell Variant in Idiopathic Pulmonary Fibrosis. Sci Transl Med 15(693):eabp9528, 2023. e-Pub 2023. PMID: 37099633.
54. Al-Tashi Q, Saad MB, Muneer A, Qureshi R, Mirjalili S, Sheshadri A, Le X, Vokes NI, Zhang J, Wu J. Machine Learning Models for the Identification of Prognostic and Predictive Cancer Biomarkers: A Systematic Review. Int J Mol Sci 24(9), 2023. e-Pub 2023. PMID: 37175487.
55. Alkhunaizi M, Patel B, Bueno L, Bhan N, Ahmed T, Arain MH, Saliba R, Rondon G, Dickey BF, Bashoura L, Ost DE, Li L, Wang S, Shpall E, Champlin RE, Mehta R, Popat UR, Hosing C, Alousi AM, Sheshadri A. Risk Factors for Bronchiolitis Obliterans Syndrome after Initial Detection of Pulmonary Impairment after Hematopoietic Cell Transplantation. Transplant Cell Ther 29(3):204.e1-204.e7, 2023. e-Pub 2023. PMID: 36503180.
56. Cheng GS, Crothers K, Aliberti S, Bergeron A, Boeckh M, Chien JW, Cilloniz C, Cohen K, Dean N, Dela Cruz CS, Dickson RP, Greninger AL, Hage CA, Hohl TM, Holland SM, Jones BE, Keane J, Metersky M, Miller R, Puel A, Ramirez J, Restrepo MI, Sheshadri A, Staitieh B, Tarrand J, Winthrop KL, Wunderink RG, Evans SE. Immunocompromised Host Pneumonia: Definitions and Diagnostic Criteria: An Official American Thoracic Society Workshop Report. Ann Am Thorac Soc 20(3):341-353, 2023. e-Pub 2023. PMID: 36856712.
57. Aminu M, Daver N, Godoy MCB, Shroff G, Wu C, Torre-Sada LF, Goizueta A, Shannon VR, Faiz SA, Altan M, Garcia-Manero G, Kantarjian H, Ravandi-Kashani F, Kadia T, Konopleva M, DiNardo C, Pierce S, Naing A, Kim ST, Kontoyiannis DP, Khawaja F, Chung C, Wu J, Sheshadri A. Heterogenous lung inflammation CT patterns distinguish pneumonia and immune checkpoint inhibitor pneumonitis and complement blood biomarkers in acute myeloid leukemia: Proof of concept. Front Immunol 14:1249511, 2023. e-Pub 2023. PMID: 37841255.
58. Aminu M, Yadav D, Hong L, Young E, Edelkamp P, Saad M, Salehjahromi M, Chen P, Sujit SJ, Chen MM, Sabloff B, Gladish G, de Groot PM, Godoy MCB, Cascone T, Vokes NI, Zhang J, Brock KK, Daver N, Woodman SE, Tawbi HA, Sheshadri A, Lee JJ, Jaffray D, Team D, Wu CC, Chung C, Wu J. Habitat Imaging Biomarkers for Diagnosis and Prognosis in Cancer Patients Infected with COVID-19. Cancers (Basel) 15(1), 2022. e-Pub 2022. PMID: 36612278.
59. Xu T, Wu L, Gandhi S, Jing W, Nguyen QN, Chen A, Chang JY, Nurieva R, Sheshadri A, Altan M, Lee PP, Lin SH, Liao Z. Treatment-related pulmonary adverse events induced by chemoradiation and Durvalumab affect survival in locally advanced non-small cell lung cancer. Radiother Oncol 176:149-156, 2022. e-Pub 2022. PMID: 36209942.
60. Mendoza TR, Hong DS, Peterson CB, Stephen B, Dumbrava E, Pant S, Tsimberidou AM, Yap TA, Sheshadri A, Altan M, George G, Castillo L, Rodriguez E, Gong J, Subbiah V, Janku F, Fu S, Piha-Paul SA, Ahnert JR, Karp DD, Cleeland C, Meric-Bernstam F, Naing A. Patient-Reported Symptom Burden in Patients with Rare Cancers Receiving Pembrolizumab in a Phase II Clinical Trial. Sci Rep 12(1):14367, 2022. e-Pub 2022. PMID: 35999229.
61. Trivedi AP, Hall C, Goss CW, Lew D, Krings JG, McGregor MC, Samant M, Sieren JP, Li H, Schechtman KB, Schirm J, McEleney S, Peterson S, Moore WC, Bleecker ER, Meyers DA, Israel E, Washko GR, Levy BD, Leader JK, Wenzel SE, Fahy JV, Schiebler ML, Fain SB, Jarjour NN, Mauger DT, Reinhardt JM, Newell JD, Hoffman EA, Castro M, Sheshadri A, Program (SARP) NSAR. Quantitative CT Characteristics of Cluster Phenotypes in the Severe Asthma Research Program Cohorts. Radiology 304(2):450-459, 2022. e-Pub 2022. PMID: 35471111.
62. Sheshadri A, Goizueta AA, Shannon VR, London D, Garcia-Manero G, Kantarjian HM, Ravandi-Kashani F, Kadia TM, Konopleva MY, DiNardo CD, Pierce S, Zarifa A, Albittar AA, Zhong LL, Akhmedzhanov FO, Arain MH, Alfayez M, Alotaibi A, Altan M, Naing A, Mendoza TR, Godoy MCB, Shroff G, Kim ST, Faiz SA, Kontoyiannis DP, Khawaja F, Jennings K, Daver NG. Pneumonitis after immune checkpoint inhibitor therapies in patients with acute myeloid leukemia: a retrospective cohort study. Cancer 128(14):2736-2745, 2022. e-Pub 2022. PMID: 35452134.
63. Sheshadri A, Sacks NC, Healey BE, Raza S, Boerner G, Huang HJ. Lung Function Monitoring After Lung Transplantation and Allogeneic Hematopoietic Stem Cell Transplantation. Clin Ther 44(5):755-765.e6, 2022. e-Pub 2022. PMID: 35513911.
64. Sacks NC, Healey BE, Raza S, Cyr PL, Boerner G, Sheshadri A. The Economic Burden of NIPC and BOS Following allogeneic HSCT in Patients with Commercial Insurance in the United States. Blood Adv 6(5):1566-1576, 2022. e-Pub 2022. PMID: 34807973.
65. Sheshadri A, Makhnoon S, Alousi AM, Bashoura L, Andrade R, Miller CJ, Stolar KR, Arain MH, Noor L, Balagani A, Jain A, Blanco D, Ortiz A, Taylor MS, Stenzler A, Mehta R, Popat UR, Hosing C, Ost DE, Champlin RE, Dickey BF, Peterson SK. Home-based spirometry telemonitoring after allogeneic hematopoietic cell transplantation: a mixed methods evaluation of acceptability and usability. JMIR Form Res 6(2):e29393, 2022. e-Pub 2022. PMID: 35129455.
66. Trivedi A, Hall C, Goss C, Lew D, Krings J, McGregor M, Samant M, Sieren J, Li H, Schechtman K, Schirm J, McEleney S, Peterson S, Moore W, Bleecker E, Meyers D, Israel E, Washko G, Levy B, Leader J, Wenzel S, Fahy J, Schiebler M, Fain S, Jarjour N, Mauger D, Reinhardt J, Newell J, Hoffman E, Castro M, Sheshadri A. Quantitative Computed Tomographic Characteristics of Cluster Phenotypes in the Severe Asthma Research Program Cohorts. Radiology, 2022. e-Pub 2022.
67. Sheshadri A, Sacks NC, Healey B, Cyr P, Boerner G, Huang HJ. The healthcare resource utilization and costs of chronic lung allograft dysfunction following lung transplantation in patients with commercial insurance in the United States. J Med Econ 25(1):650-659, 2022. e-Pub 2022. PMID: 35502563.
68. Patel B, Sheshadri A, Faiz SA. Cavitary Lesions in a Hematopoietic Stem Cell Transplant Patient. Arch Bronconeumol 57(12):768, 2021. e-Pub 2020. PMID: 32576396.
69. Patel B, Sheshadri A, Faiz SA. Cavitary Lesions in a Hematopoietic Stem Cell Transplant Patient. Arch Bronconeumol 57(12):768, 2021. e-Pub 2021. PMID: 35698985.
70. Wolff D, Radojcic V, Lafyatis R, Cinar R, Rosenstein RK, Cowen EW, Cheng GS, Sheshadri A, Bergeron A, Williams KM, Todd JL, Teshima T, Cuvelier GDE, Holler E, McCurdy SR, Jenq RR, Hanash AM, Jacobsohn D, Santomasso BD, Jain S, Ogawa Y, Steven P, Luo ZK, Dietrich-Ntoukas T, Saban D, Bilic E, Penack O, Griffith LM, Cowden M, Martin PJ, Greinix HT, Sarantopoulos S, Socie G, Blazar BR, Pidala J, Kitko CL, Couriel DR, Cutler C, Schultz KR, Pavletic SZ, Lee SJ, Paczesny S. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. The 2020 Highly morbid forms report. Transplant Cell Ther 27(10):817-835, 2021. e-Pub 2021. PMID: 34217703.
71. Krings JG, Goss CW, Lew D, Samant M, McGregor MC, Boomer J, Bacharier LB, Sheshadri A, Hall C, Brownell J, Schechtman KB, Peterson S, McEleney S, Mauger DT, Fahy JV, Fain SB, Denlinger LC, Israel E, Washko G, Hoffman E, Wenzel SE, Castro M, Heart N, Lung, Program Investigators ABISAR. Quantitative CT metrics are associated with longitudinal lung function decline and future asthma exacerbations: results from SARP-3. J Allergy Clin Immunol 148(3):752-762, 2021. e-Pub 2021. PMID: 33577895.
72. Turner J, He Q, Baker K, Chung L, Lazarevic-Fogelquist A, Bethune D, Hubbard J, Guerriero M, Sheshadri A, Syrjala KL, Martin PJ, Boeckh M, Lee SJ, Gooley T, Flowers ME, Cheng GS. Home Spirometry Telemonitoring for Early Detection of Bronchiolitis Obliterans Syndrome in Patients with Chronic Graft Versus Host Disease. Transplant Cell Ther 27(7):616.e1-616.e6, 2021. e-Pub 2021. PMID: 33781975.
73. Sheshadri A, Keus L, Blanco D, Lei X, Kellner C, Shannon VR, Balachandran DD, Jimenez CA, Bashoura L, Faiz SA. Pulmonary function testing in patients with tracheostomies: feasibility and technical considerations. Lung 199(3):307-310, 2021. e-Pub 2021. PMID: 33779802.
74. Evans SE, Jennerich AL, Azar MM, Cao B, Crothers K, Dickson RP, Herold S, Jain S, Madhavan A, Metersky ML, Myers LC, Oren E, Restrepo MI, Semret M, Sheshadri A, Wunderink RG, Dela Cruz CS. Nucleic Acid-based Testing for Noninfluenza Viral Pathogens in Adults with Suspected Community-acquired Pneumonia. An Official American Thoracic Society Clinical Practice Guideline. Am J Respir Crit Care Med 203(9):1070-1087, 2021. e-Pub 2021. PMID: 33929301.
75. Sheshadri A, Saliba R, Patel B, Ahmed T, Bueno LC, Arain MH, Mehta RS, Popat UR, Hosing CM, Rondon G, Bashoura L, Dickey BF, Champlin RE, Alousi AM. Azithromycin may increase hematologic relapse rates in matched unrelated donor hematopoietic cell transplant recipients who receive anti-thymocyte globulin, but not in most other recipients. Bone Marrow Transplant 56(3):745-748, 2021. e-Pub 2020. PMID: 33009515.
76. Sagar AES, Landaeta MF, Adrianza AM, Aldana GL, Pozo L, Armas-Villalba A, Toquica CC, Larson AJ, Vial MR, Grosu HB, Ost DE, Eapen GA, Sheshadri A, Morice RC, Shannon VR, Bashoura L, Balachandran DD, Almeida FA, Uzbeck MH, Casal RF, Faiz SA, Jimenez CA. Complications following symptom limited thoracentesis using suction. Eur Respir J 56(5), 2020. e-Pub 2020. PMID: 32499336.
77. Lai KA, Sheshadri A, Adrianza AM, Etchegaray M, Balachandran DD, Bashoura L, Shannon VR, Faiz SA. Role of Infliximab in Immune Checkpoint Inhibitor-Induced Pneumonitis. J Immunother Precis Oncol 3(4):172-174, 2020. e-Pub 2020. PMID: 35665375.
78. Sheshadri A, Alousi A, Bashoura L, Stolar K, Baghaie S, Arain MH, Noor L, Balagani A, Jain A, Blanco D, Ortiz A, Peterson SK, Langhals R, Taylor M, Stenzler A, Mehta RS, Popat UR, Hosing C, Rondon G, Shen F, Li L, Cheng GS, Ost DE, Champlin RE, Dickey BF. Feasibility and Reliability of Home-based Spirometry Telemonitoring in Allogeneic Hematopoietic Cell Transplant Recipients. Ann Am Thorac Soc 17(10):1329-1333, 2020. e-Pub 2020. PMID: 32614241.
79. Mendoza T, Sheshadri A, Altan M, Hess K, George G, Stephen B, Castillo L, Rodriguez E, Gong J, Peterson C, Rodon Ahnert J, Fu S, Piha-Paul SA, Pant S, Dumbrava E, Yap TA, Janku F, Tsimberidou AM, Subbiah V, Karp DD, Zarifa A, McQuinn LM, Cleeland C, Hong DS, Naing A. Evaluating the psychometric properties of the Immunotherapy module of the MD Anderson Symptom Inventory. J Immunother Cancer 8(2), 2020. e-Pub 2020. PMID: 33097611.
80. Bailey M, Eapen G, Ost D, Casal RF, Jimenez C, Datar S, Molina S, Bashoura L, Faiz SA, Balachandran DD, Shannon VR, Sheshadri A, Grosu HB. Routine Microbiologic Studies of Pleural Fluid Specimens in Cancer Patients. Am J Med 133(2):240-244, 2020. e-Pub 2020. PMID: 31401163.
81. Grosu HB, Lu W, Ost DE, Vial MR, Hernandez M, Ghosh N, Noor L, Hasan AM, Bashoura L, Faiz S, Balachandran D, Casal R, Eapen G, Shannon V, Sheshadri A, Tang X, Rahman N, Wistuba II. Pleural Fluid Cytokine Levels at Baseline and Over Time are Associated With Time to IPC Removal: An Exploratory Study. J Bronchology Interv Pulmonol 27(1):4-13, 2020. e-Pub 2020. PMID: 31373905.
82. Kim ST, Sheshadri A, Shannon V, Kontoyiannis DP, Kantarjian H, Garcia-Manero G, Ravandi F, Im JS, Boddu P, Bashoura L, Balachandran DD, Evans SE, Faiz S, Ruiz Vazquez W, Divenko M, Mathur R, Tippen SP, Gumbs C, Neelapu SS, Naing A, Wang L, Diab A, Futreal A, Nurieva R, Daver N. Distinct Immunophenotypes of T Cells in Bronchoalveolar Lavage Fluid From Leukemia Patients With Immune Checkpoint Inhibitors-Related Pulmonary Complications. Front Immunol 11:590494, 2020. e-Pub 2020. PMID: 33552049.
83. Sheshadri A, Karimipour M, Vakil E, Bashoura L, Godoy M, Arain MH, Evans SE, Dickey BF, Ost DE, Chemaly RF, Faiz SA. Refinement of estimates of mortality risk using the Radiologic Severity Index in hematologic malignancy patients with respiratory syncytial virus infection. Transpl Infect Dis 21(4):e13105, 2019. e-Pub 2019. PMID: 31081570.
84. Sheshadri A, Chemaly RF, Alousi AM, Shah PK, Rondon G, Bashoura L, Kmeid J, Azzi J, Blanco DW, Kaous M, Dickey BF, Champlin RE, Shah DP. Pulmonary impairment following respiratory viral infections is associated with high mortality in allogeneic hematopoietic cell transplant recipients. Biol Blood Marrow Transplant 25(4):800-809, 2019. e-Pub 2019. PMID: 30521974.
85. Sheshadri A, Godoy M, Erasmus JJ, Gruschkus S, Hasan A, Evans SE, Barreda-Garcia J, Chemaly RF, Dickey B, Ost D. Progression of the Radiologic Severity Index is associated with increased mortality and healthcare resource utilisation in acute leukaemia patients with pneumonia. BMJ Open Respir Res 6(1):e000471, 2019. e-Pub 2019. PMID: 31921429.
86. Debiane L, Reitzel R, Rosenblatt J, Gagea M, Chavez MA, Adachi R, Grosu HB, Sheshadri A, Hill LR, Raad I, Ost DE. A Design-Based Stereologic Method to Quantify the Tissue Changes Associated with a Novel Drug-Eluting Tracheobronchial Stent. Respiration 98(1):1-10, 2019. e-Pub 2019. PMID: 30799409.
87. Vakil E, Sheshadri A, Faiz SA, Shah DP, Zhu Y, Li L, Kmeid J, Azzi J, Balagani A, Bashoura L, Ariza-Heredia E, Chemaly RF. Risk factors for mortality after respiratory syncytial virus lower respiratory tract infection in adults with hematologic malignancies. Transpl Infect Dis 20(6):e12994, 2018. e-Pub 2018. PMID: 30195271.
88. Patel S, Leavey A, Sheshadri A, Kumar P, Kandikuppa S, Tarsi J, Mukhopadhyay K, Johnson P, Balakrishnan K, Schechtman KB, Castro M, Yadama G, Biswas P. Associations between Household Air Pollution and Reduced Lung Function in Women and Children in Rural Southern India. Journal of Applied Tocicology 38(11):1405-1415, 2018. e-Pub 2018. PMID: 30047157.
89. Colen RR, Fujii T, Bilen MA, Kotrotsou A, Abrol S, Hess KR, Hajjar J, Suarez-Almazor ME, Alshawa A, Hong DS, Giniebra-Camejo D, Stephen B, Subbiah V, Sheshadri A, Mendoza T, Fu S, Sharma P, Meric-Bernstam F, Naing A. Radiomics to predict immunotherapy-induced pneumonitis: proof of concept. Invest New Drugs 36(4):601-607, 2018. e-Pub 2018. PMID: 29075985.
90. Fujii T, Colen RR, Bilen MA, Hess KR, Hajjar J, Suarez-Almazor ME, Alshawa A, Hong DS, Tsimberidou A, Janku F, Gong J, Stephen B, Subbiah V, Piha-Paul SA, Fu S, Sharma P, Mendoza T, Patel A, Thirumurthi S, Sheshadri A, Meric-Bernstam F, Naing A. Incidence of immune-related adverse events and its association with treatment outcomes: the MD Anderson Cancer Center experience. Invest New Drugs 36(4):638-646, 2018. e-Pub 2018. PMID: 29159766.
91. Balagani A, Arain M, Sheshadri A. Case report: Bronchiolitis obliterans after combination immunotherapy with pembrolizumab and ipilimumab. J Immunother Precis Oncol 1(1):49-52, 2018. e-Pub 2018.
92. Ontiveros N, Eapen-John D, Osorio N, Song J, Li L, Sheshadri A, Tiang X, Ghosh N, Vaporciyan A, Correa A, Walsh G, Grosu HB, Ost DE. Predicting post-operative lung function following lobectomy: a new method to adjust for inherent selection bias. Respiration 96(5):434-445, 2018. e-Pub 2018. PMID: 30257257.
93. Sheshadri A, Shah DP, Godoy M, Erasmus JJ, Song J, Li L, Evans SE, Chemaly RF, Dickey BF, Ost DE. Progression of the Radiologic Severity Index Predicts Mortality in Patients with Parainfluenza Virus-Associated Lower Respiratory Infections. PLoS One 13(5):e0197418, 2018. e-Pub 2018. PMID: 29771962.
94. Valley T, Sheshadri A, Hoopman T. A young man with empyema: a report of isolated fusobacterial disease. Infect Dis Clin Pract 19(6):e31-e32, 2011. e-Pub 2011.
95. Sheshadri A, Rajaram R, Baugh A, Castro M, Correa A, Soto F, Daniel-MacDougall C, Evans S, Dickey B, Vaporciyan A, Ost D. Prediction of pulmonary complications after lobectomy in non-small cell lung cancer using race-neutral and race-specific normative pulmonary function equations.

Invited Articles

1. Azhar M, Abrencillo R, Gandhi S, Altan M, Sheshadri A. Immunotherapy-related pneumonitis and the synergic impact of thoracic radiation and preexisting interstitial lung disease. Curr Opin Pulm Med 29(4):248-255, 2023. e-Pub 2023. PMID: 37170920.
2. Bertini CD, Khawaja F, Sheshadri A. Coronavirus Disease-2019 in the Immunocompromised Host. Clin Chest Med 44(2):395-406, 2023. e-Pub 2023. PMID: 37085228.
3. Jain A, Shannon V, Sheshadri A. Pneumonitis after precision oncology therapies: a concise review. Journal of Immunotherapy and Precision Oncology 1(1):26-37, 2018. e-Pub 2018.
4. Sheshadri A, Castro M, Chen A. Bronchial thermoplasty: a novel therapy for severe asthma. Clin Chest Med 34(3):437-444, 2013. e-Pub 2013. PMID: 23993815.
5. Sheshadri A, Carson Tyler Moss, Joe L. Hsu, Mayur Ramesh, Gail M. Gauvreau, Jane Tumer, MyLinh Duong, Rick Nettles, Jason Chien, Ella Neqrou, Fafa Boateng, Dimitri Talantov, Guang-Shing Cheng. The burden of community-acquired respiratory viral infections in high-risk immunocompromised patients post the COVID-19 pandemic. American Journal of Respiratory and Critical Care Medicine:A6562 - A6562, 2009.

Review Articles

1. Moura MJ, Chatterjee A, Wali S, Garza DR, Salim H, Rong J, Menon R, Jafri F, Urias Rivera A, Mortan R, Palaskas NL, Reynolds KL, Leaf RK, Kikani N, Thomas A, Zhang HC, Wang LS, Tummala S, Al-Zubidi N, Sheshadri A, Abudayyeh A, Jeff YL, Wang Y. Refractory immune-related adverse events (irAEs) associated with immune checkpoint inhibitor therapy: a multiorgan management review. Expert Opin Drug Saf:1-14, 2026. e-Pub 2026. PMID: 41995025.
2. Zafar B, Haque T, Tan M, Singh R, Bashoura L, Sheshadri A, Azhar M, Faiz SA. Pulmonary Complications of Cancer Therapy: Clinical Presentations, Imaging Patterns, and Management Strategies. Medicina (Kaunas) 62(3), 2026. e-Pub 2026. PMID: 41901659.
3. Ngo S, Rong J, Menon R, Colli Cruz C, Chatterjee A, Mortan R, Salim H, Urias Rivera A, Jafri FI, Garza D, Kim S, Funchain P, Zhang HC, Sheshadri A, Ernstoff M, Neilan T, Oo T, Roeland E, Moshiri A, Wang Y. Chronic sequelae of immune-related adverse events. Expert Opin Drug Saf, 2026. e-Pub 2026. PMID: 41729184.
4. Rong J, Jafri F, Ngo S, Chatterjee A, Moura Nascimento Santos MJ, Garza D, Salim H, Menon R, Mortan R, Urias Rivera AC, Zhang HC, Patel A, Rojas Hernandez C, Jeff Li Y, Sheshadri A, Aaroe A, Shariff A, Schneider B, Thomas A, Wang Y. Rare irAEs associated with immune checkpoint inhibitor therapy. Expert Opin Drug Saf:1-15, 2026. e-Pub 2026. PMID: 41664562.
5. Bhyravabhotla K, Gaskey G, Walder JR, Balachandran DD, Cherian SV, Zafar B, Bashoura L, Sheshadri A, Faiz SA. Intrathoracic manifestations of hematologic malignancies: a narrative review. Ann Transl Med 13(6):81, 2025. e-Pub 2025. PMID: 41502434.
6. Bertini, CD, Soto, F, Brown, R, Bashoura, L, Cheng, GS, Hensley, MK, Hsu, JL, Lai, YK, Sharifi, H, Sturek, JM, Yanik, G, Yadav, H, Faiz, S, Sheshadri, A. Noninfectious pulmonary complications after hematopoietic cell transplantation. Respiratory Medicine 248, 2025. e-Pub 2025. PMID: 40902833.
7. Bade, BC, Faiz, S, Tan, M, Baugh, A, Lavercombe, M, Sheshadri, A. The Impact of Health Care Disparities on Lung Cancer Screening and Treatment. Chest 168(4):1057-1066, 2025. e-Pub 2025. PMID: 40350147.
8. Khoury, M, Faiz, S, Sheshadri, A. Immune checkpoint inhibitor-associated pneumonitis. Current opinion in pulmonary medicine 31(4):335-343, 2025. e-Pub 2025. PMID: 40265506.
9. Lassell RKF, Pritchard K, Baehr LA, Ceide ME, Chatterjee SA, Colon-Semenza C, Jayakody O, Lieber SB, Loewenthal JV, Mosher CL, Myasoedova E, Na A, Makris U, Sherman A, Sheshadri A, Wagle K, Wingood M, Andonian BJ. New horizons in advancing lifestyle medicine for older adults utilizing a transdisciplinary approach: gaps and opportunities. Age Ageing 54(6), 2025. e-Pub 2025. PMID: 40511981.
10. Singh N, Faye AS, Abidi MZ, Grant SJ, DuMontier C, Iyer AS, Jain N, Kochar B, Lieber SB, Litke R, Loewenthal JV, Masters MC, Nanna MG, Robison RD, Sattui SE, Sheshadri A, Shi SM, Sherman AN, Walston JD, Wysham KD, Orkaby AR. Frailty integration in medical specialties: Current evidence and suggested strategies from the Clin-STAR frailty interest group. J Am Geriatr Soc 73(4):1029-1040, 2025. e-Pub 2025. PMID: 39584362.
11. Mir M, Faiz S, Bommakanti AG, Sheshadri A. Pulmonary Immunocompromise in Stem Cell Transplantation and Cellular Therapy. Clin Chest Med 46(1):129-147, 2025. e-Pub 2025. PMID: 39890284.
12. Bertini, CD, Khawaja, F, Sheshadri, A. Coronavirus Disease-2019 in the Immunocompromised Host. Rheumatic Disease Clinics of North America 51(1):123-138, 2025. e-Pub 2025. PMID: 39550101.
13. Li, C, Faiz, S, Boysen-Osborn, M, Sheshadri, A, Wattana, M. Immune Checkpoint Inhibitor-associated Pneumonitis. Western Journal of Emergency Medicine 26(2):210-218, 2025. e-Pub 2025. PMID: 40145913.
14. Chan, KL, Faiz, S, Altan, M, Sheshadri, A. Updates in Drug-Related Pneumonitis Due to Targeted Oncologic Therapies. Journal of Immunotherapy and Precision Oncology 7(4):272-282, 2024. e-Pub 2024. PMID: 39524467.
15. Auld SC, Sheshadri A, Alexander-Brett J, Aschner Y, Barczak AK, Basil MC, Cohen KA, Dela Cruz C, McGroder C, Restrepo MI, Ridge KM, Schnapp LM, Traber K, Wunderink RG, Zhang D, Ziady A, Attia EF, Carter J, Chalmers JD, Crothers K, Feldman C, Jones BE, Kaminski N, Keane J, Lewinsohn D, Metersky M, Mizgerd JP, Morris A, Ramirez J, Samarasinghe AE, Staitieh BS, Stek C, Sun J, Evans SE. Postinfectious Pulmonary Complications: Establishing Research Priorities to Advance the Field: An Official American Thoracic Society Workshop Report. Ann Am Thorac Soc 21(9):1219-1237, 2024. e-Pub 2024. PMID: 39051991.
16. Sheshadri A, Scott E Evans. Respiratory Syncytial Virus Vaccination in the Adult Pulmonary Patient. ELSEVIER 166(5):963-974, 2024. e-Pub 2024. PMID: 38885895.
17. Girish S. Shroff MD, Sheshadri A, Mehmet Altan MD, Mylene T. Truong MD, Lauren T. Erasmus, Ioannis Vlahos MBBS. Drug-induced Lung Disease in the Oncology Patient: From Cytotoxic Agents to Immunotherapy. Clinics in Chest Medicine 45(2):325-337, 2024. e-Pub 2024. PMID: 38816091.
18. Bertini, CD, Khawaja, F, Sheshadri, A. Coronavirus Disease-2019 in the Immunocompromised Host. Infectious Disease Clinics of North America 38(1):213-228, 2024. e-Pub 2024. PMID: 38280765.
19. Keam, S, Turner, N, Grande Kugeratski, F, Rico, R, Colunga-Minutti, JG, Poojary, R, Alekseev, S, Patel, A, Li, YJ, Sheshadri, A, Loghin, ME, Woodman, K, Aaroe, AE, Hamidi, S, Iyer, PC, Palaskas, NL, Wang, Y, Nurieva, R. Toxicity in the era of immune checkpoint inhibitor therapy. Frontiers in immunology 15, 2024. e-Pub 2024. PMID: 39247203.
20. Jose RJ, Dickey BF, Sheshadri A. Airway disease in hematologic malignancies. Expert Rev Respir Med 16(3):303-313, 2022. e-Pub 2022. PMID: 35176948.
21. Shroff GS, Strange CD, Ahuja J, Altan M, Sheshadri A, Unlu E, Truong MT, Vlahos I. Imaging of Immune Checkpoint Inhibitor Immunotherapy for Non-Small Cell Lung Cancer. Radiographics 42(7):1956-1974, 2022. e-Pub 2022. PMID: 36240075.

Other Articles

1. Mir M, Soto F, Gomez PAA, Arroyo RDR, Suresh A, Su A, Gan Q, Stewart J, Adachi R, Balachandran DD, Bashoura L, Casal RF, Dickey BF, Eapen GA, Evans SE, Grosu H, Jimenez CA, Lin J, Ost DE, Sabath BF, Shannon VR, Naing A, Gao J, Wu J, Suresh K, Faiz SA, Altan M, Sheshadri A Correction: Bronchoalveolar lavage cell percentages as diagnostic markers of immune checkpoint inhibitor pneumonitis. Front Med (Lausanne) 12:1646108, 2025. PMID: 40641984.
2. Alkhunaizi M, Patel B, Bueno L, Bhan N, Ahmed T, Arain MH, Saliba R, Rondon G, Dickey BF, Bashoura L, Ost DE, Li L, Wang S, Shpall E, Champlin RE, Mehta R, Popat UR, Hosing C, Alousi AM, Sheshadri A Corrigendum to 'Risk Factors for Bronchiolitis Obliterans Syndrome after Initial Detection of Pulmonary Impairment after Hematopoietic Cell Transplantation' [Transplantation and Cellular Therapy 29/3 (2023) 204-204]. Transplant Cell Ther 32(5):628, 2024. PMID: 39561968.

Editorials

1. Chan, KL, Faiz, S, Sheshadri, A. Antibody-Drug Conjugate–Induced Pneumonitis. Journal of Immunotherapy and Precision Oncology 8(2):141-142, 2025. PMID: 40242271.
2. Sun CY, Elia J, Prather AA, Sheshadri A. Digital Lifestyle Interventions in CKD: No Better Time Than Now. Kidney Int Rep 9(12):3358-3361, 2024. PMID: 39698358.
3. Sheshadri A, Huang HJ, Bashoura L, Alousi AM, Alkhunaizi M, Sharifi H, Hsu JL. Graft-versus-host disease may cause pulmonary restriction, but not all restriction is graft-versus-host disease. Blood Adv 6(17):4984-4986, 2022. PMID: 35793452.
4. Sheshadri A. Quantitative lung imaging in hematopoietic cell transplant recipients: a window into the physiology of bronchiolitis obliterans. Chest 158(3):852-853, 2020. PMID: 32892879.

Abstracts

1. Sheshadri A, Jose Carlos Tuesta, Alexia Dayan Lecaros Zavalla, Abdelrahman M. Attia, Ivan Alexander Flores Hernandez, Emilio Jacques Villarreal, Saadia A. Faiz, Aung Naing, Funda Meric-Bernstam, Bora Lim. TRASTUZUMAB DERUXTECAN-ASSOCIATED PNEUMONITIS IN NONBREAST SOLID TUMORS. American College of Chest Physicians 2026. e-Pub 2026.
2. Sheshadri A, Katherine V. Dudamel, Mtanis Khoury, Saadia A. Faiz. Pulmonary Manifestations of Adverse Events Related to Cancer Treatments:1-17, 2026.
3. Sheshadri A, Luis Diaz Tejada, Fabiana Príncipe, Abdelrahman M. Attia, Ivan Alexander Flores Hernandez, Emilio Jacques Villarreal, Omar Alhalabi, Matthew Campbell, Cindy Jiang, mehmet altan. INCIDENCE AND RISK FACTORS FOR PNEUMONITIS IN PATIENTS WITH UROTHELIAL CARCINOMA TREATED WITH ENFORTUMAB VEDOTIN WITH PEMBROLIZUMAB. American College of Chest Physicians 2026. e-Pub 2026.
4. Sheshadri A, Brock, K, Grosu, H, Saniz, P, Young, C, Ferguson, J, Li, L, Andersen, C, Lu, S, OConnor, C, Robles, S, Hakawa, A, Soto, F. COPD classifier abstract to the CHEST. e-Pub 2026.
5. Sheshadri A, James Tran,, Victor Mulanovich,, Scott Evans,, Alexander Franklin,, Adam G. Stewart,, Ying Jiang,, Blake Hanson,, Micah M. Bhatti,, Teny M. John. Retrospective Assessment of the Potential Clinical Impact of multiplex PCR and targeted NGS for Diagnosing Pulmonary Infections in Immunocompromised Patients. ESCMID 2026. e-Pub 2026.
6. Sheshadri A, Oziel Alonso Guerra Rubi, Juhee Song, Ph.D., Nicolas Palaskas, M.D, Salil Kumar, M.D., Elie Mouhayar, M.D., Jean-Bernard Durand, M.D., Reza Mehran, M.D., Kyle Mitchell, M.D., Anita Deswal, M.D.,, Ravi Rajaram, M.D, Hyeon-Ju Ryoo Ali, M.D.. PULMONARY HYPERTENSION POST-MAJOR LUNG RESECTION: INCIDENCE AND RISK FACTORS. e-Pub 2025.
7. Sheshadri A, Mohammad I Ghanbar, Andres Villabona-Rueda, Nicolas Philip, Romy Rodriguez Ortega, Shannon Fonti, Arabellis Wally, Haiyang Jiang, Rulin Wang, Wilhelm Berger, Jeffrey Thiboutot, Hans Lee, Patrick Forde, Jarushka Naidoo, Julie Brahmer, Sang Taek Kim, Naval Daver, Mehmet Altan, Pierre Van Mol, Els Wauters, Francois-Xavier Danlos, Jerome Le Pavec, Ariane Laparra, Rachel Damico, Srinivasan Yegnasubramanian, Sonye Danoff, Franco D'Alessio, Karthik Suresh. Macrophage CCL18 Promotes Lung Inflammation in Checkpoint Inhibitor Pneumonitis. AJRCMB, 2025. e-Pub 2025. PMID: 41072117.
8. Sheshadri A, C.Mollings Puentes, Y.M Sasaki, S. Koutroumpakis, A. Deswal, Q.N. Nguyen, D.Qian, J.Bronk, S. Gandhi, 1 T Cascone, M. Altan, A.B. Chen, Z. Liao, T. Xu, X. Le. CCI as a Predictive Tool of Treatment Tolerance and Outcomes in Elderly NSCLC Patients Treated with Concurrent Proton or Photon Chemoradiation followed by Immunotherapy, 2025.
9. Sheshadri A. SEVERE PULMONARY ARTERIAL HYPERTENSION POST LOBECTOMY FOR LUNG CANCER. American College of Chest Physicians 2025. e-Pub 2025.
10. Sheshadri A, Gregory Gaskey, Gloria Mensah, Mazen Aiche, Sarah Forsythe, Mitchell Boshkos, Fernando Camacho, Luis Luna, Anum Waqar, Jaimie Duano, Jhankruti Zaveri, Annie Shen, Girish Shroff, Dave Balachandran, Saadia A. Faiz, Tito Mendoza, Jia Wu, Pablo Bravo Lopez, Saumil Gandhi, Steven Lin, Zhongxing Liao, Aung Naing, Xin Shelley Wang, Mehmet Altan. Analysis of patient reported outcomes and ambulatory spirometry ability to detect pneumonitis. e-Pub 2025.
11. Sheshadri A, Sung-Yeon Cho, Sebastian Wurster, Takahiro Matsuo, Dimitrios P. Kontoyiannis. Cellular Composition of Bronchoalveolar Lavage Fluid in Patients with Hematologic Malig-nancies and Invasive Pulmonary Aspergillosis: Significant Associations with Peripheral Blood Cell Counts. The University of Texas MD Anderson Cancer Center, 2024. e-Pub 2024.
12. Glick L, Soto F, Wilson NR, Zhong LL, Akhmedzanov FO, Xu F, Franco-Vega MC, Clavijo S, Shannon VR, Faiz SA, Gandhi S, Naing A, Heymach JV, Palaskas N, Altan M, Sheshadri A. Factors Associated with One Year Survival among Patients with Non-Small Cell Lung Cancer who Develop Immune Checkpoint Inhibitor Pneumonitis. American College of Chest Physicians 2023. e-Pub 2023.
13. Glick L, Iliescu C, Koutroumpakis E, Altan M, Deswal A, Sheshadri A, Palaskas N. Factors associated with One Year Survival among Patients who Develop Immune Checkpoint Inhibitor Myocarditis. American College of Chest Physicians 2023. e-Pub 2023.
14. Minshall ME, Kemp DR, Hofstetter E, Boerner G, McGrain J, Siddiqui SJ, Levine DJ, Sheshadri A. The Comparative Humanistic Burden of Bronchiolitis Obliterans Syndrome (BOS) on Patients Undergoing Lung Transplant (LTX) or Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT) in the United States. American Journal of Respiratory and Critical Care Medicine:207:A4854, 2023. e-Pub 2023.
15. Ebinama U, Sheshadri A, Ahmed S, Lee HJ, Liu M, Iyer SP. Risk of Pneumonitis with Immune Checkpoint Inhibitors in Hodgkin’s Lymphoma and Other Hematologic Malignancies: A Retrospective Review from Pharmacovigilance. American Society of Hematology, 2022. e-Pub 2022.
16. Altan M, Sheshadri A. Auto reactive antibodies as predictive markers for immune checkpoint induced pneumonitis, 2022. e-Pub 2022.
17. Sheshadri A. Restrictive Decline in Pulmonary Function Testing After Hematopoietic Stem Cell Transplant: A Look at Etiology and Prognosis. ATS 2022. e-Pub 2022.
18. Alkhunaizi MA, Saliba R, Patel B, Arain M, Mehta R, Popat U, Hosing C, Rondon G, Bashoura L, Bhan N, Dickey B, Champlin R, Alousi A, Sheshadri A. Restrictive Lung Impairment After Hematopoietic Stem Cell Transplant: Etiology and Impact. American Thoracic Society 2022, 2022. e-Pub 2022.
19. Sheshadri A, Madelyn Peha, Kelsey Baker, Chad He, Elizabeth Rankin, Maggie Guerriero, Jane Turner, Joe Hsu, Husham Sharifi, Greg Yanik, Guang-Shing Cheng. Detection of FEV1 decline preceding bronchiolitis obliterans syndrome diagnosis in allogeneic hematopoietic stem cell transplant recipients. ATS 2021. e-Pub 2021.
20. Sheshadri A, Mehmet Altan, Linda Zhong, Kristofer Jennings, Felipe Soto, Fareed Khawaja, Girish Shroff, Vickie R. Shannon, Fechukwu O. Akhmedzhanov, Abdulrazzak Zarifa, Muhammad H. Arain, Tanbin Rahman, Jeff Lewis, Waree Rinsurongkawong, Jack Lee, Vadeerat Rinsurongkawong, Jianjun Zhang, Don Gibbons, Ara Vaporciyan, Jianjun Zhang, Don Gibbons, Ara Vaporciyan, Jianjun Zhang, Tito Mendoza, Aung Naing, John V. Heymach. Incidence and Risk Factors for Pneumonitis Associated with Immune Checkpoint Inhibitors in Advanced-stage Nonsmall Cell Lung Cancer: a Single Center Experience. IOTOX Scientific Symposium, 2021. e-Pub 2021.
21. Sheshadri A, Lirong Wu, Ting Xu, Saumil Gandhi, Steven Lin, Wang Jing, Quynh-Nhu Nguyen, Aileen Chen, Joe Chang, Mehmet Altan, Anne Tsao,, Roza Nurieva, James Welsh, Percy Lee, Zhongxing Liao. Pulmonary Adverse Events after Real World Adjuvant Immune Checkpoint Inhibitor (ICI) Therapy and Its Impact on Survival for Locally Advanced Non-Small Cell Lung Cancer. ARS Annual Meeting, 2021.
22. Sheshadri A, Linda Zhong, Felipe Soto, Vickie R. Shannon, Fechukwu O. Akhmedzhanov, Abdulrazzak Zarifa, Muhammad H. Arain, John Heymach,, Tanbin Rahman, Jeff Lewis, Jeff Lewis, Waree Rinsurongkawong, Jack Lee, Jianjun Zhang, Jack Roth, Stephen Swisher, Tito Mendoza, Aung Naing, Mehmet Altan. Incidence and Risk Factors for Pneumonitis Associated with Immune Checkpoint Inhibitors in Advanced-stage Nonsmall Cell Lung Cancer. NSCLC ICI ASCO, 2020.
23. Mendoza TR, Hong D, Naing A, Hess KR, Sheshadri A, Altan M, Stephen BA, Cleeland C. Evaluating the psychometric properties of the immunotherapy module of the MD Anderson Symptom Inventory (MDASI-Immunotherapy), 2019. e-Pub 2019.
24. Patel B, Sheshadri A, Saliba R, Rondon G, Ahmed T, Arain M, Mehta R, Popat U, Hosing C, Bashoura L, Dickey B, Champlin R, Alousi A. Azithromycin Exposure Following Hematopoietic Stem Cell Transplantation Is Associated with an Increased Risk of Cancer Relapse in Acute Leukemia. Biology of Blood and Marrow Transplantation 25(3):S100-S289, 2019. e-Pub 2019.
25. Sheshadri A, Godoy M, Erasmus J, Arain M, Evans S, Barreda-Garcia J, Chemaly R, Dickey B, Ost D. Progression of the Radiologic Severity Index is associated with increased mortality in patients with acute leukemia who develop pneumonia after induction chemotherapy. American Journal of Respiratory and Critical Care Medicine 199, 2019. e-Pub 2019.
26. Sheshadri A, Naomi C. Sacks, Bridget Healey, Philip L. Cyr, Katharine Batt, Noreen Roth Henig. Lung function monitoring of allogenic hematopoietic stem cell transplant (alloHSCT) patients, 2019.
27. Sang K, Shannon V, Sheshadri A, Kantarjian H, Garcia-Manero G, Ravandi F, Naing A, Sharma P, Im J, Ruiz Vasquez W, Diab A, Kontoyiannis D, Futreal A, Daver N. Immunophenotypic Analysis of T Cells from Leukemia Patients with Immune Checkpoint Inhibitor-Associated Respiratory Complications. American College of Rheumatology, 2018. e-Pub 2018.
28. Sood S, Sajol G, Goss C, Sheshadri A, Comhair A, Erzurum S, Hall C, Weaver R, Schutz R, Kozlowski J, Castro M. Longitudinal evaluation of airway remodeling in asthma over time by airway biopsy. American Journal of Respiratory and Critical Care Medicine 197, 2018. e-Pub 2018.
29. Sheshadri A, Balagani A, Alousi A, Bashoura L, Stolar K, Arain M, Noor L, Blanco D, Ortiz A, Goodwin N, Chen M, Li L, Hess K, Chemaly R, Ost D, Peterson S, Champlin R, Dickey B. Feasibility and Validity of a Home-based Spirometry Program after Hematopoietic Stem Cell Transplantation for the Early Detection of Pulmonary Impairment. American Journal of Respiratory and Critical Care Medicine 197, 2018. e-Pub 2018.
30. Kim S, Shannon V, Sheshadri A, Kantarjian H, Garcia-Manero G, Im J, Ravandi F, Naing A, Sharma P, Kontoyiannis D, Futreal A, Daver N. Th1/17 Cells are Expanded in Bronchial Alveolar Lavage (BAL) Fluid from Leukemia Patients with Checkpoint Inhibitor-Induced Pneumonitis. Blood 130:3588, 2017. e-Pub 2017.
31. Hall C, Trivedi AP, Sheshadri A, Boomer J, Yin Declue H, Sajol G, Goss C, Kozlowski J, Gierada D, Sieren JP, Escher M, Schutz R, Li H, Schechtman KB, Moore WC, Bleecker ER, Hofman EA, Castro M, Program (SARP) OBOTNSAR. Airway Remodeling Measured by Targeted Biopsies in Severe Asthma. American Journal of Respiratory and Critical Care Medicine 195, 2017. e-Pub 2017.
32. Sheshadri A, Kmeid J, Azzi J, Kaous M, Blanco D, Bashoura L, Rondon G, Alousi A, Dickey B, Chemaly R, Shah D. Pulmonary Function Decline after Respiratory Viral Infection Predicts Mortality after Hematopoetic Cell Transplantation. American Thoracic Society, 2017. e-Pub 2017.
33. Trivedi A, Sheshadri A, Goss C, Sieren J, Escher M, Schutz R, Li H, Schechtman K, Moore W, Bleecker E, Hoffman E, Castro M. The Use Of CT To Characterize Cluster Phenotypes In The Severe Asthma Research Program. American Journal of Respiratory and Critical Care Medicine 195:A5153, 2017. e-Pub 2017.
34. Sheshadri A, Dimpy Shah, Myrna Godoy, Jeremy Erasmus, Juhee Song, Liang Li, Scott Evans, Roy Chemaly, Burton Dickey, David Ost. Progression of Radiologic Infiltrates after Parainfluenza Infection Predicts Mortality in Patients with Hematologic Malignancies. PIV MD Anderson, 2017. e-Pub 2017.
35. Sheshadri A, Jiao J, Carlstrom L, Sieren JP, Escher M, Sajol G, Yin-Declue H, Tarsi J, Schutz R, Wilson B, Li H, Schechtman K, Moore WC, Bleecker ER, Hoffman EA, Castro M. MDCT Characteristics of Pre-Specified Asthmatic Cluster Phenotypes in the Severe Asthma Research Program. American Journal of Respiratory and Critical Care Medicine 191:A2490, 2015. e-Pub 2015.
36. Sarikonda K, Sheshadri A, Koch T, Kozlowski J, Wilson B, Schechtman K, Chen A, Castro M. Predictors of bronchial thermoplasty response in patients with severe refractory asthma. American Thoracic Society 2014 International Conference, 2014. e-Pub 2014.
37. Sheshadri A, Rodriguez A, Chen R, Kozlowski J, Burgdorf D, Koch T, Tarsi J, Sajol G, Yin-Declue H, Wilson B, Schechtman K, Castro M, Fain S, Gierada D. Reducing Field of View in Multi-Detector Quantitative Computed Tomography Improves Accuracy of Measures of Airway Wall Remodeling. American Journal of Respiratory and Critical Care Medicine, 2014. e-Pub 2014.
38. Sarikonda K, Sheshadri A, Koch T, Kozlowski J, Wilson B, Schechtman K, Chen A, Castro M. Predictors of Bronchial Thermoplasty Response in Patients with Severe Refractory Asthma. American Journal of Respiratory and Critical Care Medicine, 2014. e-Pub 2014.
39. Sheshadri A, Thomen R, Kozlowski J, Gierada D, Tarsi J, Koch T, Burgdorf D, Sajol G, Yin-DeClue H, Wilson B, Schechtman K, Quirk J, Castro M, Woods J. Ventilation defects with hyperpolarized helium MRI in severe asthma before and after bronchial thermoplasty 187, 2013. e-Pub 2013.
40. Thomen R, Sheshadri A, Kozlowski J, Quirk J, Chang Y, Castro M, Woods J. Ventilation Quantification Bronchopulmonary Segments in Severe Asthma Using 3He MRI and High Resolution CT 187, 2013. e-Pub 2013.
41. Sheshadri A, Witt C, Gierada D, Kozlowski J, Hoffman EA, Cook-Granroth J, Fain SB, Busse WW, Zheng J, Wilson B, Schechtman K, Castro M. Predictors of Airway Remodeling and Decline in Lung Function in Severe Asthma 185, 2012. e-Pub 2012.
42. Sheshadri A, Mineo C, Yuhanna IS, Shaul PW. Inhibition of HDL-mediated eNOSactivation by the SR-BI inhibitor glyburide, 2005. e-Pub 2005.
43. Sheshadri A, Husham Sharifi, Zayan Musa, Carson Tyler Moss, Alex Bell, Christian O’Donnell, Carlos Hernandez Borges, Efthymia Iliana Matthaiou, Laura Johnston, Craig Galban, Gregory Yanik, Guang-Shing Cheng, Joe L. Hsu. STOP BOS abstract ATS 2025.
44. Sharifi H, Bertini CD, Alkhunaizi MA, Hernandez M, Turk I, Bashoura L, Dickey B, Cheng G, Yanik G, Galban C, Godoy M, Guo HH, Reinhardt J, Hoffman E, Castro M, Alousi AM, Champlin RE, Shpall EJ, Rondon, G, Peterson S, Datta K, McEleney S, Hsu JL, Sheshadri A. Distinguishing Early Bronchiolitis Syndrome After Hematopoietic Cell Transplantation Using Novel Lung Strain Metrics from Chest CT Scans. CHEST.
45. Sheshadri A. The Use Of Cardiopulmonary Exercise Testing In The Pre-operative Evaluation Of Lobectomy Patients Within The Veterans Health Administration.
46. Lanza F, Wilson N, Zhong L, Franco-Vega M, Simbaqueba C, Khawaja F, Shannon V, Liao Z, Ghandi S, Xu T, Sheshadri A, Altan M. ESMO PACIFIC #5607 Pneumonitis after chemoradiation and consolidation durvalumab for locally advanced non-small cell lung cancer: a single center experience.
47. Sheshadri A, Patel, A, Palaskas, N, Pauken, K, Champiat, S, Cole, A, Zuri, Q, Lu, S, Nguyen, M, Abudayyeh, A, Rojas Hernandez, C, Li, Y, Manzano, J, Wang, Y. ITOP Abstract.
48. Sheshadri A. Bronchiolitis Obliterans Syndrome after Lung Transplantation: Economic Burden by CLAD Stage. International Society for Heart and Lung Transplantation.
49. Gordon N, Kleinerman ES, Sheshadri A, Blanco DW, Yedururi S, Morani A, Gill JB, Harrison DJ, Herzog CE, Livingston JA, Benjamin RS, Mireles ME, Kawedia J, Daw NC. A Phase I Trial of Aerosol Gemcitabine for the Treatment of Patients with Solid Tumors and Lung Metastases. Journal of Clinical Oncology 38(15).
50. Xian W, Mckeon F, Huang H, Safdar Z, Vincent M, Boucher R, Dickey B, Engelhardt J, Crum C, Karmouty-Quintana H, Sheshadri A, Parekh K, Schwartz D, Metersky M, Wechsler M. The Spectrum And Pathogenicity Of Clonogenic Basal Cells In Lung Disease. ATS 2024.
51. Sheshadri A. INTERSTITIAL LUNG DISEASE AFTER COVID-19 IN PATIENTS WITH CANCER AND WITHOUT: A PROSPECTIVE COHORT STUDY. American College of Chest Physicians.
52. Mir Mahnoor, Pedro Antonio Amezcua Gómez, Qiong Gan, john stewart, Roberto Adachi, Diwakar D. Balachandran, Lara Bashoura, Roberto F. Casal, Burton Dickey, George A. Eapen, Scott E. Evans, Horiana B. Grosu, Julie Lin, David E. Ost, Bruce F. Sabath, Vickie R. Shannon, Aung Naing, Jia Wu, Karthik Suresh, Saadia A. Faiz, Sheshadri A. Bronchoalveolar lavage (BAL) lymphocytosis as a predictive marker of Immune checkpoint inhibitor (ICI) Pneumonitis – a retrospective analysis. American College of Chest Physicians.
53. Sheshadri A, Husham Sharifi, Christopher D. Bertini, Mansour Alkhunaizi, Maria Hernandez, Zayan Musa, Carlos Borges, Ihsan Turk, Lara Bashoura, Burton F. Dickey, Guang-Shing Cheng, Gregory Yanik, Craig J. Galban, Henry Guo, Myrna C.B. Godoy, Joseph Reinhardt, Eric A. Hoffman, Mario Castro, Gabriela Rondon, Amin M. Alousi, Richard E. Champlin, Elizabeth J. Shpall, Ying Lu, Samuel Peterson, Keshav Datta, Stephen McEleney, Mark Nicolls, Joe Hsu. DISTINGUISHING EARLY BRONCHIOLITIS OBLITERANS SYNDROME AFTER HEMATOPOIETIC CELL TRANSPLANTATION USING NOVEL LUNG STRAIN METRICS FROM CHEST CT SCANS. Chest 2023 Annual Meeting.
54. Sheshadri A. HYPERCAPNIC RESPIRATORY INSUFFICIENCY ASSOCIATED WITH DUAL IMMUNE CHECKPOINT INHIBITORS IN A PATIENT WITH RENAL CELL CARCINOMA. American College of Chest Physicians.
55. Sheshadri A, Maria Azhar. INCIDENCE AND RISK FACTORS FOR PNEUMONITIS DUE TO TRASTUZUMAB DERUXTECAN IN FEMALES WITH BREAST CANCER. American College of Chest Physicians 2024.
56. Austin Chen, Kevin Ng, Sheshadri A, Joe Hsu, Husham Sharifi, Greg Yanik, Kelsey Baker, Yeheun Cho, Cheryl Sung, Margaret Guerriero, Mike Vo, Michael Boeckh, Stephanie Lee, Paul Carpenter, Ted Gooley, Chad He, Guang-Shing Cheng. FEV1 Trajectory in a Prospective Cohort of Bronchiolitis Obliterans Syndrome after Hematopoietic Cell Transplant Cohort. ATS 2025.
57. Vo, M., Baker, K, Sheshadri A, Sharifi, H, Hsu, J, Yanik, G, Cho, Y, Crotty, B, Boullin, M, Chen, A, Lee, S, Bender -Ignacio, R, Waghmare, A, Carpenter, P, Gooley, T, He, Q, Boeckh, M, Cheng, G. Asymptomatic and Symptomatic Respiratory Viral Infections With Chronic Graft-versus-host Disease And Bronchiolitis Obliterans Syndrome After Allogeneic Hematopoietic Cell Transplant. American Thoracic Society 2025.
58. M. Amjad, , I. Zugast, S. Urrutia, Sheshadri A, E. Saul, G. Garcia-Manero. Short Telomere Syndromes And The Co-occurrence Of Myelodysplastic Syndromes And Idiopathic Pulmonary Fibrosis. ATS 2025 International Conference.
59. Sheshadri A. DIAGNOSIS OF MALIGNANT PLEURAL EFFUSION IN HEMATOLOGIC MALIGNANCIES. 2025 AABIP Annual Conference.
60. Sheshadri A, S. Chambers, B. Sayeed, M. Smolkin, V. Deepak;. Endometrial Stroma-Lined Cystic Lesions in the Lung: A Rare Case Report. ATS 2026.
61. Sheshadri A, T. Saber, N. E. Lange, J. C. Kennedy. Familial Presentation of Flcn Variant (p. Trp376arg): A Family Case Series of Birt-Hogg-Dubé Syndrome Supporting Reclassification Toward Pathogenicity. ATS 2026.
62. Sheshadri A, Abdelrahman M Attia. Incidence and risk factors for pneumonitis in patients with urothelial carcinoma treated with enfortumab vedotin plus pembrolizumab: A retrospective cohort study. 2026 ASCO Annual Meeting.
63. Sheshadri A, Gregory Gaskey MD, Mazen Aiche MD. Incidence and risk factors for pneumonitis after check point inhibitor immunotherapy in patients with genitourinary cancers.
64. Chan, Kathy, Sheshadri, Ajay. Sleep Disturbances in Lung Cancer Patients Based on Patient Reported Outcomes and Polysomnography. Sleep 2024.
65. Sheshadri A, Mitchell Boshkos, Amgad Muneer, Eman Showkatian, Felipe Soto, Fernando Camacho,, Gregory Gaskey, Mazen Aiche, Sarah Forsythe, Karthik Suresh, Rupali Sood, Mo Ghanbar, Sam Peterson, Joshua Schirm, Kevin Ho, Girish Shroff, Hai Tran, Jack Lee, Jianjun Zhang, Don Gibbons, John Heymach, Aung Naing, Saadia A. Faiz, Jia Wu, Mehmet Altan. Lower lobe and total lung quantitative fibrosis scores identified by quantitative CT predict pneumonitis risk in non–small cell lung cancer (NSCLC). American Thoracic Society.
66. Walder J, Soto-Lanza F, Ahmed S, Neelapu S, Ayers A, Grosu HB, Faiz SA, Nastoupil, Sheshadri A. Role of Pulmonary Function Tests to Predict Respiratory and Non-Respiratory Complications after Chimeric Antigen Receptor T-Cell Therapy. American College of Chest Physicians 2023.
67. Sheshadri A. Pulmonary hypertension in patients with chronic myeloproliferative neoplasms.
68. Bhyravabhotla, Kshama, Sheshadri. Increased Sleep Disruption in Patients with Advanced Cancer Undergoing Immunotherapy. Sleep 2024.
69. Sheshadri A, Mazen Aiche, Sarah Forsythe, Gregory Gaskey, Mitchell Boshkos, Fernando Camacho, Luis Luna, Jhankruti Zaveri, Jaime Duano, Anum Waqar, Xin Shelley Wang, Girish Shroff, Diwakar Balachandran, Saadia A. Faiz, Karthik Suresh, Kevin Ho, Jia Wu, Pablo Bravo Lopez, Saumil Gandhi, Steven Lin, Zhongxing Liao, Aung Naing, Mehmet Altan. Association of Pre-Treatment Interstitial Lung Abnormalities in Patients with Locally Advanced Non-Smell Lung Cancer with Risk for Immune Checkpoint Inhibitor Pneumonitis.
70. Sheshadri A, Rodridguez A, Chen R, Kozlowski J, Burgdorf D, Koch T, Tarsi J, Sajol G, Yin-Declue H, Wilson B, Schechtman K, Castro M, Fain S, Gierada D. Reducing Field of View in Multi-Detector Quantitative Computed Tomography Improves Accuracy of Measures of Airway Wall Remodeling. FOV.
71. Sood S, Mazzola G, Sheshadri A, Goss C, Comhair S, Erzurum S, Hall C, Weaver R, Schutz R, Kozlowski J, Castro M. Longitudinal evaluation of airway remodeling in asthma over time by airway biopsy. ATS 2018.
72. Sheshadri A, W. Xian, F. Mckeon, H. J. Huang, Z. Safdar, M. Vincent, R. Boucher, B. Dickey, J. F. Engelhardt, C. Crum, H. Karmouty-Quintana, K. R. Parekh, D. A. Schwartz, M. L. Metersky, M. E. Wechsler. The Spectrum And Pathogenicity Of Clonogenic Basal Cells In Lung Disease. ATS 2024.

Book Chapters

1. Farooq, S, Faiz, S, Shannon, VR, Sheshadri, A. Immune Checkpoint Inhibitor Therapy Induced Relapsing Pneumonitis, 377-385, 2025.
2. Farooq, S, Faiz, S, Shannon, VR, Sheshadri, A. Pneumonitis and COVID-19 Pneumonia Post Immune Checkpoint Inhibitor Therapy, 387-396, 2025.
3. Farooq, S, Faiz, S, Shannon, VR, Sheshadri, A. Immune Checkpoint Inhibitor Associated Pneumonitis in a Patient with Interstitial Lung Abnormalities, 397-405, 2025.
4. Farooq S, Faiz S, Shannon V, Altan M, Sheshadri A. In: Challenging Cases in Immunotherapy Related Organ Toxicities. Springer, 2024.
5. Farooq S, Faiz S, Shannon V, Altan M, Sheshadri A. Infliximab for the treatment of steroid-dependent immune checkpoint inhibitor pneumonitis. In: Challenging Cases in Immunotherapy Related Organ Toxicities. Springer, 2024.
6. Farooq S, Faiz S, Shannon V, Altan M, Sheshadri A. In: Challenging Cases in Immunotherapy Related Organ Toxicities. Springer, 2024.
7. Mehta, RS, Sheshadri, A, Alousi, AM. An Overview of Graft-Versus-Host Disease, 17-44, 2023.
8. Alkhunaizi, M, José, RJ, Sheshadri, A. Pretransplant Pulmonary Evaluation, 63-79, 2023.
9. Sheshadri A, Sacks NC, Huang HJ, Cyr P, Healey B, Boerner G. NIPC after lung transplant. In: Journal of Medical Economics, 2022.
10. Verma, D, Faiz, S, Shannon, VR, Sheshadri, A, Altan, M. Pulmonology (Lung), 275-299, 2022.
11. Altan M, Zhong L, Shannon VR, Sheshadri A. Pulmonary Toxicities of Immunotherapy. In: Immunotherapy. 4th. Springer, 357-375, 2021.
12. Aslam W, Sheshadri A, Lamb C. Chapter 12: Bronchial Thermoplasty. In: Practical Guide to Interventional Pulmonology. 1. Elsevier, 2020.
13. Zhong L, Altan M, Shannon VR, Sheshadri A. Immune-related Adverse Events: Pneumonitis. In: Adv Exp Med Biol, 255-269, 2020.
14. Jain A, Shannon VR, Sheshadri A. Immune-related Adverse Events: Pneumonitis. In: Adv Exp Med Biol. 2nd, 131-149, 2018.
15. Sarikonda K, Sheshadri A, Castro M. Asthma. In: The Washington Manual of Outpatient Medicine. 2nd. Lippincott, Williams & Wilkins, 2015.
16. Sheshadri A, Castro M. Asthma. In: The Washington Manual of Medical Therapeutics. 34th ed. Lippincott, Williams & Wilkins, 2013.
17. Atkinson J, Senior R, Sheshadri A, Castro M. Obstructive Lung Disease. In: The Washington Manual of Medical Therapeutics. 34th ed. Lippincott, Williams & Wilkins, 2013.
18. Sheshadri A. Bone Marrow and Blood Stem Cell TRANSPLANTS. In: A Guide for Patients and Their Loved Ones.
19. S Farooq, SA Faiz, VR Shannon, Sheshadri A. Pneumonitis and COVID-19 Pneumonia Post Immune Checkpoint Inhibitor Therapy. In: Challenging Cases in Immunotherapy Related Organ Toxicities. SPRINGER NATURE.
20. S Farooq, SA Faiz, VR Shannon, Sheshadri A. Immune Checkpoint Inhibitor Associated Pneumonitis in a Patient with Interstitial Lung Abnormalities. In: Challenging Cases in Immunotherapy Related Organ Toxicities. SPRINGER NATURE.
21. Shannon V, Eapen G, Jimenez C, Grosu H, Morice RC, Bashoura L, Sheshadri A, Evans S, Adachi R, Kroll M, Faiz S, Balachandran D, Pravinkumar S, Dickey B. Respiratory Complication. In: Cancer Medicine. 10.
22. Verma D, Faiz SA, Shannon VR, Altan M, Sheshadri A. Pulmonary toxicities after immune checkpoint inhibitor therapies. In: Managing Immunotherapy Related Organ Toxicities: A practical guide. Springer.
23. S Farooq, SA Faiz, VR Shannon, Sheshadri A. Immune Checkpoint Inhibitor Therapy Induced Relapsing Pneumonitis. In: Challenging Cases in Immunotherapy Related Organ Toxicities. SPRINGER NATURE.

Books (edited and written)

1. Sheshadri A. Murray & Nadel's Textbook of Respiratory Medicine. Ed(s) 8th Edition. Elsevier, 2025.